跳至主要内容
临床试验/PACTR202405890935254
PACTR202405890935254尚未招募Unknown

A non-interventional clinical validation study of the Exponential Deep Examination (EDE) scanner in the detection of human immunodeficiency virus (HIV), tuberculosis (TB) and malaria

EDE Research Institute0 个研究点目标入组 2,320 人开始时间: 2024年2月27日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
2,320

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
All

入选标准

  • Inclusion criteria
  • For Group 1 (symptomatic patients suspected of HIV/TB/malaria/HCV):
  • Male or female, aged =18 years
  • Asymptomatic/symptomatic patients suspected of HIV, or symptomatic patients suspected of TB,
  • malaria, or HCV based on physician’s clinical evaluation, which may include laboratory (eg, liver
  • function tests, CBC) or radiological (eg, chest X-ray) tests per routine clinical practice
  • Patient agrees to undergo the non-invasive EDE scanner test and standard diagnostic testing for the
  • respective infectious disease (HIV/TB/malaria/HCV) - per routine standard of care, in parallel
  • Provision of signed informed consent
  • For Group 2 (healthy participants):
  • Male or female, aged =18 years
  • Healthy participant, as determined by physician’s judgment
  • Participant undergoing routine blood test as per standard of care
  • Participant agrees to undergo non-invasive EDE scanner test
  • Participant permits use of the routine blood sample to conduct a standard diagnostic test for HIV,
  • malaria, or HCV; or, participant agrees to provide a sputum sample to conduct a standard diagnostic test
  • No evidence of active infectious disease or any infectious disease in the past 8 weeks
  • No history of any of the following in the past 6 months (at minimum): close contact with infected
  • patients or infectious disease department, open/unprotected relations, drug abuse, blood transfusions
  • Provision of signed informed consent
  • For Group 3 (suspected MDR-TB patients):
  • Male or female, aged =18 years
  • Patients with documented pulmonary TB due to strains of Mycobacterium tuberculosis, currently on TB
  • treatment as per routine clinical practice and suspected of MDR-TB based on physician’s clinical
  • evaluation (eg, lack of treatment response to both isoniazid and rifampicin)
  • Patient agrees to undergo the non-invasive EDE scanner test and standard diagnostic testing for MDRTB (per routine standard of care), in parallel
  • Provision of signed informed consent

排除标准

  • Exclusion criteria
  • For Group 1 (symptomatic patients suspected of HIV/TB/malaria/HCV):
  • Current or previous history of treatment for HIV, TB, malaria, or HCV
  • Patients suspected to be co-infected with more than one of the infectious diseases of interest
  • (HIV/TB/malaria/HCV)
  • Current or previous participation in any investigational drug or medical device study in the past 3
  • Patients on any concomitant antibiotic or antiviral treatment
  • For Group 2 (healthy participants):
  • Current or previous participation in any investigational drug or medical device study in the past 3
  • Participants on any concomitant antibiotic or antiviral treatment
  • For Group 3 (suspected MDR-TB patients):
  • Previous history of treatment for MDR-TB or extensive drug resistance TB (XDR-TB)
  • Current or previous participation in any investigational drug or medical device study in the past 3
  • Patients on any concomitant antibiotic or antiviral treatment

研究者

发起方
EDE Research Institute

相似试验